Butterfly Network (BFLY) drew fresh attention after announcing a multi-year licensing deal with Merge Labs that centers on its Poseidon Ultrasound-on-Chip platform for brain-computer interface development.
The Butterfly Network share price has rallied 95.47% year to date, and the 1 year total shareholder return of 341.57% points to a powerful rebound, even though the 30 day share price return declined 17.08% after a strong 29.73% gain over 90 days that helped set the stage for today’s reaction to the Merge Labs licensing deal.
Use this move by Butterfly Network as a reference point and scan for other healthcare AI plays with potential catalysts in our curated list of 39 healthcare AI stocks.
Butterfly Network now trades at a sizeable discount to analyst targets after a sharp rerating on the Merge deal. Is that discount a safety buffer, or a warning the market remains unconvinced?
Most Popular Narrative: 31% Undervalued
Compared with the most followed fair value estimate of $10.67, Butterfly Network at $7.33 is framed as materially discounted. This puts a lot of weight on its ability to turn product traction and AI tools into durable revenue.
Progress on the HomeCare pilot, targeting large populations of heart failure patients with portable, AI-assisted ultrasound and remote specialist diagnosis, validates Butterfly's unique position to capitalize on the healthcare trend toward preventive, decentralized care. This has the potential to generate significant new revenue and improve net margins as contracts expand state
and nation-wide.
See why 35 investors see Butterfly Network as 31% undervalued.
Result: Fair Value of $10.67 (UNDERVALUED)
Still, the Butterfly Network story can change quickly if large enterprise deals stall or international projects pause. Such developments would challenge those optimistic growth assumptions.
Find out about the key risks to this Butterfly Network narrative.
Another View On Butterfly Network Valuation
On pure pricing, Butterfly Network tells a very different story. The stock trades on a P/S ratio of 17.4x, while the US Medical Equipment industry sits around 2.9x and close peers average 3.5x. The fair ratio estimate of 5.9x suggests the current multiple leans heavily to the rich side. If growth or execution wobbles, how much patience will the market really have with a premium this wide?
For a closer look at how this pricing gap lines up against fundamentals, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals around Butterfly Network valuation can feel messy, so move quickly, test the numbers yourself, and pressure test both the upside and downside using our breakdown of 2 key rewards and 3 important warning signs.
Looking for more Butterfly Network style investment ideas?
Do not stop at Butterfly Network alone. Use focused screeners to surface fresh candidates that match the kind of risk, value, or income profile you actually want.
- Target potential mispricings by scanning a curated pool of companies that score well on quality and valuation using the 32 high quality undervalued stocks.
- Protect your downside by filtering for businesses with strong finances and dependable fundamentals through our list of solid balance sheet and fundamentals (23 results).
- Stack income potential on top of capital return prospects by zeroing in on companies in the 6 dividend fortresses that focus on higher yields and resilience.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com